Acetic Acid

Acetic Acid

SCHEMBL4630472

CC(=O)O.CC(C)Oc1cccc(Oc2ccc(N)cc2)c1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.61
SMN1; SMN2 Q16637 3/20 0.61
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
MITF O75030 1/20 0.61
GAA P10253 1/20 0.61
MAPT P10636 1/20 0.61
GFER P55789 1/20 0.61
NLRP1 Q9C000 1/20 0.61
NOD2 Q9HC29 1/20 0.61
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
NLRP3 Q96P20 1/20 0.50
MAOA P21397 1/20 0.50
ACACB O00763 2/20 0.49
ACACA Q13085 1/20 0.49
PTGS1 P23219 1/20 0.48
MAOB P27338 1/20 0.46
RXRA P19793 1/20 0.46
RXRB P28702 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL4630467 0.85 PARP10 (0.64) ALDH1A1MEN1KMT2AACACBACACA
Acetic Acid SCHEMBL4630370 0.84 SMN1; SMN2 (0.81) ALDH1A1SMN1; SMN2MEN1KMT2AMITF
4-Phenoxyaniline SCHEMBL4630332 0.82 MAOA (0.75) ALDH1A1SMN1; SMN2MEN1KMT2AMITF
Acetic Acid SCHEMBL4630421 0.79 SMN1; SMN2 (0.57) ALDH1A1SMN1; SMN2MEN1KMT2AMITF
SCHEMBL554191 0.78 ALDH1A1 (0.91) ALDH1A1SMN1; SMN2MEN1KMT2AMITF
SCHEMBL6290623 0.78 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2MEN1KMT2AMITF
SCHEMBL1270594 0.78 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2MEN1KMT2AMITF
SCHEMBL6290330 0.78 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2MEN1KMT2AMITF
SCHEMBL22289568 0.78 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2MEN1KMT2AMITF
SCHEMBL1271678 0.78 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2MEN1KMT2AMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP claimed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO claimed
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP disclosed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed